NO20052676D0 - Polymorfer av bicifadin-saltsyre - Google Patents

Polymorfer av bicifadin-saltsyre

Info

Publication number
NO20052676D0
NO20052676D0 NO20052676A NO20052676A NO20052676D0 NO 20052676 D0 NO20052676 D0 NO 20052676D0 NO 20052676 A NO20052676 A NO 20052676A NO 20052676 A NO20052676 A NO 20052676A NO 20052676 D0 NO20052676 D0 NO 20052676D0
Authority
NO
Norway
Prior art keywords
bicifadin
polymorphs
hydrochloric acid
hydrochloric
acid
Prior art date
Application number
NO20052676A
Other languages
English (en)
Other versions
NO20052676L (no
Inventor
Brenton William Russell
Rex Alwyn Shipplett
Kevin John Halloran
Original Assignee
Dov Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dov Pharmaceutical Inc filed Critical Dov Pharmaceutical Inc
Publication of NO20052676D0 publication Critical patent/NO20052676D0/no
Publication of NO20052676L publication Critical patent/NO20052676L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
NO20052676A 2002-11-08 2005-06-03 Polymorfer av bicifadin-saltsyre NO20052676L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42498202P 2002-11-08 2002-11-08
PCT/US2003/035099 WO2004043920A1 (en) 2002-11-08 2003-11-05 Polymorphs of bicifadine hydrochloride
US10/702,397 US7094799B2 (en) 2002-11-08 2003-11-05 Polymorphs of bicifadine hydrochloride

Publications (2)

Publication Number Publication Date
NO20052676D0 true NO20052676D0 (no) 2005-06-03
NO20052676L NO20052676L (no) 2005-08-03

Family

ID=32314565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052676A NO20052676L (no) 2002-11-08 2005-06-03 Polymorfer av bicifadin-saltsyre

Country Status (12)

Country Link
US (2) US7094799B2 (no)
EP (1) EP1562900A4 (no)
JP (1) JP2006519162A (no)
KR (1) KR20050075382A (no)
AU (1) AU2003286889A1 (no)
BR (1) BR0315433A (no)
CA (1) CA2504732A1 (no)
MX (1) MXPA05004873A (no)
NO (1) NO20052676L (no)
PL (1) PL376604A1 (no)
RU (1) RU2005117630A (no)
WO (1) WO2004043920A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569887B2 (en) 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
PL376604A1 (pl) * 2002-11-08 2006-01-09 Dov Pharmaceuticals, Inc. Polimorfy chlorowodorku bicifadyny
US20070043100A1 (en) * 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
WO2006102029A2 (en) * 2005-03-21 2006-09-28 Dov Pharmaceutical, Inc. Methods and compositions for the treatment of urinary incontinence
US20070082939A1 (en) * 2005-07-26 2007-04-12 Lippa Arnold S Methods and compositions for the treatment of neuropathies and related disorders
JP5184354B2 (ja) 2005-07-27 2013-04-17 ユーシミクス バイオサイエンス，インク． 新規１−アリール−３−アザビシクロ［３．１．０］ヘキサン：調製および神経精神障害の処理への使用
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US20080269348A1 (en) * 2006-11-07 2008-10-30 Phil Skolnick Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) * 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
EP2167083B1 (en) * 2007-06-06 2015-10-28 Euthymics Bioscience, Inc. 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US20090048233A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination
SG2014011811A (en) 2011-09-15 2014-05-29 Demerx Inc Noribogaine salt ansolvates
EP3597189B1 (en) 2015-06-17 2022-06-01 Otsuka America Pharmaceutical, Inc. Crystalline compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196120A (en) * 1975-07-31 1980-04-01 American Cyanamid Company Azabicyclohexanes, method of use and preparation of the same
US4231935A (en) * 1975-07-31 1980-11-04 American Cyanamid Company 1-Phenyl-3-azabicyclo[3.1.0]hexanes
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US6204284B1 (en) * 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
PL376604A1 (pl) * 2002-11-08 2006-01-09 Dov Pharmaceuticals, Inc. Polimorfy chlorowodorku bicifadyny

Also Published As

Publication number Publication date
WO2004043920A8 (en) 2005-07-21
NO20052676L (no) 2005-08-03
BR0315433A (pt) 2005-08-30
US20040102638A1 (en) 2004-05-27
PL376604A1 (pl) 2006-01-09
RU2005117630A (ru) 2006-01-20
US7094799B2 (en) 2006-08-22
EP1562900A1 (en) 2005-08-17
JP2006519162A (ja) 2006-08-24
KR20050075382A (ko) 2005-07-20
US20070149599A1 (en) 2007-06-28
CA2504732A1 (en) 2004-05-27
MXPA05004873A (es) 2005-12-05
WO2004043920A1 (en) 2004-05-27
EP1562900A4 (en) 2006-07-12
AU2003286889A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
NO20052676D0 (no) Polymorfer av bicifadin-saltsyre
CY2015015I1 (el) Παραγωγη τιακουμυκινης
NO20054762D0 (no) Polymorphs of aripiprazole
CY2018005I1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
ATE410407T1 (de) Zimtsäureamidderivate
IS2894B (is) Framleiðsla sómatóstatínpeptíða
EP1680521A4 (en) PREPARATION OF TITANIUM OXIDE
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
EP1558772A4 (en) TITAN PRODUCTION
NO20052862D0 (no) Absolutt mengdebestemmelse av nukleinsyrer med RT-PCR
ITMI20020933A0 (it) Procedimento per la sintesi di clopidogrel
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
NO20052326D0 (no) Treatment of smelting by-products
NO20054875D0 (no) Syntese av 2-klormetyl-6-metylbenzosyreestere
FI20021406A0 (fi) Densiinitapaisten yhdisteiden käyttö
UA6680S (uk) Комплект етикеток
UA6675S (uk) Комплект етикеток
UA7077S (uk) Комплект етикеток
UA6799S (uk) Комплект етикеток
UA7370S (uk) Комплект етикеток
UA6562S (uk) Комплект етикеток
UA6303S (uk) Комплект етикеток
UA6800S (uk) Комплект етикеток
UA6687S (uk) Комплект етикеток
UA6561S (uk) Комплект етикеток

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application